Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 4 of the last 4 fiscal years.
-
Board fully replaced NBB
No director from three years ago is still active according to annual account 2025.
-
Busy address KBO
100 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
PARABOLIC BIOLOGICALS from Namur, company number BE0458736853, closed financial year 2025 with a result of € 89,315 after tax. For that financial year PARABOLIC BIOLOGICALS recorded a gross margin of € 91,759 and equity of € -113,586. Compared with financial year 2024, the result moved from € 15,298 to € 89,315. Profitable, and profit is growing. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 27, 2026.
€ -113,586
▲ € 89,315 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 89,315
▲ € 74,017 vs 2024
Profit after tax over the fiscal year.
€ 37,815
▲ € 36,308 vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € -132,178.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2025
€ 244,133
▼ 1% vs 2024
Loans from banks and other lenders, long and short.
€ 2,040
▼ 84% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 61
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 28,643 | € 20,334 | € 20,195 | € 91,759 | ▲ € 71,564 |
| Profit after taxes | € 32,502 | € 14,208 | € 15,298 | € 89,315 | ▲ € 74,017 |
| Equity | € -232,407 | € -218,199 | € -202,901 | € -113,586 | ▲ € 89,315 |
| Total debts | € 308,824 | € 287,565 | € 259,605 | € 246,254 | ▼ 5% |
| Cash | € 2,687 | € 2,150 | € 1,507 | € 37,815 | ▲ € 36,308 |
| Retained profit | € -250,999 | € -236,791 | € -221,493 | € -132,178 | ▲ € 89,315 |
| Bank debt | € 298,200 | € 261,550 | € 246,601 | € 244,133 | ▼ 1% |
| Balance sheet total | € 76,417 | € 69,366 | € 56,704 | € 132,669 | ▲ 134% |
Key figures of PARABOLIC BIOLOGICALS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PARABOLIC BIOLOGICALS?
What happened at PARABOLIC BIOLOGICALS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 89,315 (▲ € 74,017 vs 2024). Source: NBB ↗
- Olivier BUCHHEISTER became a director. NBB
- Dominique MAES stepped down as director. NBB
- Dominique MAES became a director. NBB
- New establishment in Namur. KBO
- Start of the company according to the CBE. KBO
In short
From € 32,502 profit in 2022 to € 89,315 profit in 2025.
Paid € 966 in corporate taxes since 2022.
Best year ever: 2025, with € 89,315 profit.
A new publication or filing at PARABOLIC BIOLOGICALS? We notify you, reason included.
Follow PARABOLIC BIOLOGICALSDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind PARABOLIC BIOLOGICALS is Olivier BUCHHEISTER.
Directors
According to the 2025 annual accounts
Olivier BUCHHEISTER
Director
since 2025
Dominique MAES
Director
since 2011 · until 2025
Establishments
Establishment units
Physical locations of this company
Avenue des Dessus de Lives(LO) 2
5101 Namur
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 100 companies are registered at this address.
All companies at this address →GEMECA CONSTRUCTION
€ 94,806 gross margin · 2024
HOLFIM
€ 49,971 gross margin · 2024
SOJADE
€ -16,470 gross margin · 2025
FRANLOUISE
€ 53,349 gross margin · 2024
INTERACTIVE ADVERTISING & MARKETING BUREAU
€ 283,694 gross margin · 2025
+95 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
AS-HOSTINGER, CY
DNS
OVH DNS
Domain
Domain
bioparabolic.com
Registered
2007-09-10
Registrar
OVH, SAS
Expires
2026-09-10
Website info
Features
Security
Details
- Company number
- 0458.736.853
- VAT number
- BE 0458.736.853
- Registered office
- Avenue des Dessus de Lives(LO) 2, 5101 Namur
- Names & denominations
- PARABOLIC BIOLOGICALS
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 5 September 1996
- Peppol
- Active · Active since 16 Dec 2025
- Activities · NACE
Vervaardiging van overige farmaceutische producten
Vervaardiging van overige farmaceutische preparaten